These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35219932)

  • 41. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.
    Patel SD; Kollar R; Troy P; Song X; Khaled M; Parra A; Pervez M
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105231. PubMed ID: 33066910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
    Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
    Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [SARS-CoV-2 infection as a thrombo-inflammatory endothelial disease].
    Samaniego F; Conte G
    Rev Med Chil; 2020 Oct; 148(10):1467-1474. PubMed ID: 33844717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thromboembolic complications of COVID-19.
    Mui LW; Lau JF; Lee HK
    Emerg Radiol; 2021 Apr; 28(2):423-429. PubMed ID: 33159219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombotic storm in coronavirus disease 2019: from underlying mechanisms to its management.
    Zebardast A; Latifi T; Shabani M; Hasanzadeh A; Danesh M; Babazadeh S; Sadeghi F
    J Med Microbiol; 2022 Nov; 71(11):. PubMed ID: 36346830
    [No Abstract]   [Full Text] [Related]  

  • 48. Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports.
    Dwiputra Hernugrahanto K; Novembri Utomo D; Hariman H; Budhiparama NC; Medika Hertanto D; Santoso D; Hogendoorn PCW
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1670-1679. PubMed ID: 33629337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Coagulopathies, thrombotic risk and anticoagulation in COVID-19].
    Peters P; Sprynger M; Lancellotti P; Oury C
    Rev Med Liege; 2020 Sup; 75(S1):86-93. PubMed ID: 33211428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019.
    Janssen R; Visser MPJ; Dofferhoff ASM; Vermeer C; Janssens W; Walk J
    Br J Nutr; 2021 Jul; 126(2):191-198. PubMed ID: 33023681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19's immuno-pathology and cardiovascular diseases.
    Nasab EM; Aghajani H; Makoei RH; Athari SS
    J Investig Med; 2023 Feb; 71(2):71-80. PubMed ID: 36647329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.
    Poh KC; Jia Tay VY; Lin SH; Chee HL; Thangavelautham S
    Singapore Med J; 2022 Jul; 63(7):350-361. PubMed ID: 33264831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Review of the Prevalence of Thromboembolic Complications among Pregnant Women Infected with COVID-19.
    Mohd Ariff NS; Abdul Halim Zaki I; Mohd Noordin Z; Md Hussin NS; Goh KW; Ming LC; Zulkifly HH
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233801
    [No Abstract]   [Full Text] [Related]  

  • 55. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19.
    D'Souza R; Malhamé I; Teshler L; Acharya G; Hunt BJ; McLintock C
    Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1110-1120. PubMed ID: 32678949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multi-factorial Mechanism Behind COVID-19 Related Thrombosis.
    Ali EW; Ibrahim IK
    Med Arch; 2022 Feb; 76(1):62-65. PubMed ID: 35422572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
    Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
    Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virchow and his triad: a question of attribution.
    Bagot CN; Arya R
    Br J Haematol; 2008 Oct; 143(2):180-90. PubMed ID: 18783400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Major coagulation disorders and parameters in COVID-19 patients.
    Teimury A; Khameneh MT; Khaledi EM
    Eur J Med Res; 2022 Feb; 27(1):25. PubMed ID: 35168674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of Thrombotic Complications in COVID-19: An Update.
    Hajra A; Mathai SV; Ball S; Bandyopadhyay D; Veyseh M; Chakraborty S; Lavie CJ; Aronow WS
    Drugs; 2020 Oct; 80(15):1553-1562. PubMed ID: 32803670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.